On Wednesday, stock price of Ohr Pharmaceutical, Inc. (OTC:OHRP) notably decreased, though on the next day the situation 
got completely different. Yesterday, OHRP jumped up 25.23%, on a traded volume of over 410 shares traded. However, what is more interesting here is that the reason for the gain is still a mystery.
Ohr has not released any news recently, thus no one has a clue about its current activities. Actually, the last announcement by the company dates from Aug 22 when they reported that Ohr was awarded a new U.S. patent named “Polymorphic and Amorphous Salt Forms of Squalamine Dilactate”. Though, since then no news on the company was to follow.
So, in case Ohr has nothing to declare, then what’s the reason for the current price move of the stock Anyways, if anything is happening with the company, it should come up soon.[BANNER]
Ohr Pharmaceutical Inc. is a publicly traded pharmaceutical development company dedicated to the clinical development of new drugs for underserved therapeutic needs. Similar to the previous one, the latest 10-Q of the company is not encouraging at all.
As of June 30, cash and cash equivalents of Ohr have decreased as compared to the previous quarter, while its total liabilities increased. At the same time, the stockholders’ deficit exceeded $3 million and the accumulated deficit remained over $21 million. Besides, Ohr incurred a huge net loss, while the revenues kept missing.
Considering these numbers, followed by the going concern status and the lack of new data on the company, the current climb for Ohr seems to be rather unsecured.
